Sales of 10 leading local drugmakers plunge in June

Published: 2010-08-09 06:57:00

Updated: 2010-08-09 06:57:00

Over the years, Korean firms had to give up the home market to powerful global companies coming in with good medicine and better marketing strategies.

According to Ubist market data, Korea’s 10 leading companies, such as Dong-A, Hanmi, Yuhan and Choong-wae, marked minus growth rates in June sa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK